Home - Products - Others - Other Targets - Thalidomide-O-C6-NH2 hydrochloride

Thalidomide-O-C6-NH2 hydrochloride

CAS No. 2245697-88-3

Thalidomide-O-C6-NH2 hydrochloride ( 4-((6-aminohexyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride )

Catalog No. M28271 CAS No. 2245697-88-3

Thalidomide-O-C6-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 Get Quote
10MG 58 Get Quote
25MG 110 Get Quote
50MG 160 Get Quote
100MG 241 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Thalidomide-O-C6-NH2 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Thalidomide-O-C6-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate.
  • Description
    Thalidomide-O-C6-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate.
  • Synonyms
    4-((6-aminohexyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    NLRP3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2245697-88-3
  • Formula Weight
    409.9
  • Molecular Formula
    C19H24ClN3O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=CC=C3OCCCCCCN)=O.[H]Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gary Glick, et al. Substituted imidazo-quinolines as nlrp3 modulators. WO2018152396A1.
molnova catalog
related products
  • t-Boc-N-amido-PEG8-a...

    t-Boc-N-amido-PEG8-acid is a PEG derivative containing a terminal carboxylic acid and Boc-protected amino group.

  • 6-Hydroxykaempferol ...

    6-Hydroxykaempferol 3-beta-rutinoside is a natural product.

  • Ertugliflozin L-pyro...

    Ertugliflozin L-pyroglutamic acid is a selective and orally active hSGLT2 inhibitor with an IC50 of 0.877 nM.